ghk-cu dosing subcutaneous injection Peptide GHK-Cu Dosing: 1.7mg/Day Injectable (2026)

Regulatory Status AOD-9604 is not FDA-approved for any medical use and is listed by the FDA as a bulk drug substance that may present safety risks. Clinical development was halted after Phase IIb trials failed to meet efficacy endpoints. Summary AOD-9604 is a synthetic analog of the HGH 177191 fragment developed for fat-metabolism research

2025 Jan

Quick reference: the math behind every concentration For those who want to understand the formula rather than just following a chart, here is the math that drives every number in this guide

With one monthly dose of Ozempic ranging from $1,000 to $1,200, 38 percent of GLP-1 users said they were microdosing to save money